Lexicon Pharmaceuticals Reports 'Positive' TLexicon Pharmaceuticals Reports Positive Top-Line Results In Phase 3 inTandem3 Study Fop-Line Results In Phase 3 inTandem3 Study For Sotagliflozin In Patients With Type 1 Diabetes
Paul Quintaro